BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18194937)

  • 1. Plasma glucagon levels suppressed by a glucose load in a man with incidental pancreatic glucagonoma.
    Mai VQ; Jones RC; Dickert JM; Clyde PW; Shakir KM
    Endocr Pract; 2007; 13(7):780-4. PubMed ID: 18194937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
    Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagonoma syndrome and necrolytic migratory erythema.
    Lobo I; Carvalho A; Amaral C; Machado S; Carvalho R
    Int J Dermatol; 2010 Jan; 49(1):24-9. PubMed ID: 20465606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro effects of somatostatin and insulin on glucagon release in a human glucagonoma.
    Waeber G; Gomez F; Chaubert P; Temler E; Chapuis G; Boulat O; Nicod P; Haefliger JA
    Clin Endocrinol (Oxf); 1997 May; 46(5):637-42. PubMed ID: 9231061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unusual case of subclinical diffuse glucagonoma coexisting with two nodules in the pancreas: characteristic features on computed tomography.
    Azemoto N; Kumagi T; Yokota T; Kuroda T; Koizumi M; Yamanishi H; Soga Y; Furukawa S; Abe M; Ikeda Y; Hiasa Y; Matsuura B; Watanabe J; Kushihata F; Onji M
    Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):e43-7. PubMed ID: 22239827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial stimulation and venous sampling for glucagonomas of the pancreas.
    Eguchi H; Tanemura M; Marubashi S; Kobayashi S; Wada H; Okita K; Iwahashi H; Imagawa A; Shimomura I; Osuga K; Umeshita K; Wakasa K; Mori M; Doki Y; Nagano H
    Hepatogastroenterology; 2012; 59(113):276-9. PubMed ID: 21940356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spleen-preserving distal pancreatectomy and lymphadenectomy for glucagonoma syndrome: A case report.
    Cao X; Wang X; Lu Y; Zhao B; Shi J; Guan Q; Zhang X
    Medicine (Baltimore); 2019 Sep; 98(38):e17037. PubMed ID: 31567941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic glucagonoma with loss of heterozygosity on chromosome 11 in multiple endocrine neoplasia type 1.
    Sarui H; Yoshimoto K; Okumura S; Kamura M; Takuno H; Ishizuka T; Takao H; Shimokawa K; Itakura M; Saji S; Yasuda K
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):511-6. PubMed ID: 9196616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic effects of chronic hyperglucagonaemia.
    Nankervis A; Proietto J; Ng KW; Alford FP; Larkins R
    Clin Endocrinol (Oxf); 1981 Oct; 15(4):325-33. PubMed ID: 6274544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic glucagonoma: treatment with liver transplantation.
    Radny P; Eigentler TK; Soennichsen K; Overkamp D; Raab HR; Viebahn R; Mueller-Horvart C; Sotlar K; Rassner G
    J Am Acad Dermatol; 2006 Feb; 54(2):344-7. PubMed ID: 16443073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and metabolic aspects of glucagonoma.
    Leichter SB
    Medicine (Baltimore); 1980 Mar; 59(2):100-13. PubMed ID: 6987481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare presentation of endocrine pancreatic tumor: a case of diffuse glucagonoma without metastasis and necrolytic migratory erythema.
    Chen HW; Chen HW; Su DH; Shun CT; Liu KL
    J Formos Med Assoc; 2005 May; 104(5):363-6. PubMed ID: 15959605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic glucagonoma: A rare variant of an uncommon neuroendocrine pancreas tumor.
    Brown K; Kristopaitis T; Yong S; Chejfec G; Pickleman J
    J Gastrointest Surg; 1998; 2(6):533-6. PubMed ID: 10457311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagonoma syndrome.
    Hashizume T; Kiryu H; Noda K; Kano T; Nakano R
    J Am Acad Dermatol; 1988 Aug; 19(2 Pt 2):377-83. PubMed ID: 2842381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
    Torre L; Vazquez JA; Blázquez E
    Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of pancreatic glucagonoma.
    Haga Y; Yanagi H; Urata J; Inada M; Shimada S; Nitahata N; Tanimura M
    Am J Gastroenterol; 1995 Dec; 90(12):2216-23. PubMed ID: 8540521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Necrolytic migratory erythema revealing glucagonoma without diabetes].
    Marty C; Bennet A; Bayle P; Danjoux M; Lalande T; Marguery MC; Bazex J
    Ann Med Interne (Paris); 2003 Dec; 154(8):552-6. PubMed ID: 15037834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagonoma: anaesthetic management.
    Gin VC; Zacharias M
    Anaesth Intensive Care; 2009 Mar; 37(2):329-30. PubMed ID: 19400510
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case report of malignant glucagonoma with a profile of immunoreactive glucagon before and after the operation].
    Ohtsuka K; Nimura Y; Takaesu H; Yokoi S; Shionoya S; Yasui K
    Nihon Shokakibyo Gakkai Zasshi; 1986 Oct; 83(10):2223-6. PubMed ID: 3029475
    [No Abstract]   [Full Text] [Related]  

  • 20. Laparoscopic resection for nonfunctioning small glucagon-producing tumor: report of a case and review of the literature.
    Yada K; Hirano S; Himeno Y; Shibata K; Matsumoto T; Aramaki M; Kawano K; Kitano S
    J Hepatobiliary Pancreat Surg; 2003; 10(5):382-5. PubMed ID: 14598140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.